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Abstract.  We have investigated the localization of 
Kexlp, a type I transmembrane  carboxypeptidase in- 
volved in precursor processing within the yeast secre- 
tory pathway.  Indirect immunofluorescence demon- 
strated the presence of Kexlp in a punctate organelle 
resembling the yeast Golgi apparatus as identified 
by Kex2p and Sec7p (Franzusoff, A., K. Redding, J. 
Crosby, R.  S. Fuller,  and R. Schekman.  1991. J.  Cell 
Biol.  112:27-37).  Glycosylation studies of Kexlp were 
consistent with a Golgi location, as Kexlp was progres- 
sively N-glycosylated in an MNNl-dependent manner. 
To address the basis of Kexlp targeting to the Golgi 
apparatus,  we examined the cellular location of a  se- 
ries of carboxy-terminal truncations of the protein. 
The results indicate that a cytoplasmically exposed 
carboxy-terminal domain is required for retention of 
this membrane protein within the Golgi apparatus.  De- 
letions of the retention region or overproduction of 
wild-type Kexlp led to mislocalization of Kexlp to the 
vacuolar membrane.  This unexpected finding is dis- 
cussed in terms of models involving either the vacuole 
as a default destination for membrane proteins,  or by 
endocytosis to the vacuole following their default lo- 
calization to the plasma membrane. 
S 
~.CREa'EO biologically active proteins and peptides are 
classically produced as precursors which undergo both 
endo- and exoproteolytic processing to release the ma- 
ture  species while traversing  the  secretory pathway. The 
KEX/gene product (Kexlp) is a carboxypeptidase, specific 
for basic amino acid residues, and is responsible for process- 
ing  proteins  secreted by Saccharomyces  cerevisiae  (Dmo- 
chowska et al., 1987; Cooper and Bussey, 1989). In conjunc- 
tion with the proteases Kex2p and dipeptidyl aminopeptidase 
A (DPAP A)  ~ (Stel3p), Kexlp proteolytically matures pro- 
teins such as c~-factor and K1 killer toxin from their precur- 
sors (for reviews see Bussey,  1988; Fuller et al.,  1988). 
Proteins that enter the secretory pathway are thought to be 
transported to the cell surface by default via a "bulk flow" 
mechanism unless they contain additional targeting informa- 
tion (Pfeffer and Rothman,  1987; Rothman,  1987; Wieland 
et al., 1987; Karrenbauer et al., 1990). Such targeting infor- 
mation is found in soluble proteins resident in the ER which 
maintain  their  localization  by containing  a retention  signal 
at their carboxy termini  (Munro and Pelham,  1987; Pelham 
et al., 1988). Deletion of the retention signal results in secre- 
tion of the soluble ER resident proteins to the cell surface. 
Soluble proteins destined for the mammalian  lysosome re- 
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ceive a mannose-6-phosphate  signal which targets  them to 
the lysosome in a receptor-mediated manner.  The absence 
of the mannose-6-phosphate  signal from these soluble pro- 
teins results in their secretion (for review see Kornfield and 
Mellman,  1989).  Secretion  also occurs when the targeting 
signals for yeast-soluble proteins destined for the lysosome- 
like vacuole are altered  (Vails et al.,  1987; Johnson et al., 
1987; Klionsky et al.,  1988). 
In addition to soluble proteins,  the cell surface appears to 
be the default destination  for mammalian  ER, Golgi, and 
lysosomal membrane proteins as removal of their respective 
retention/targeting  signals  results  in  their  delivery to the 
plasma membrane (Machamer and Rose, 1987; Jackson et 
al., 1990; Williams and Fukuda, 1990). As yet, no targeting 
or retention  signals have been definitively assigned to yeast 
Golgi or vacuolar membrane proteins,  nor is it known where 
these proteins are delivered upon perturbation of  their target- 
ing signals. 
Kexlp is predicted to be a type I transmembrane  protein 
with a large amino-terminal  protease domain  in the lumen 
of the secretory pathway, a single membrane-spanning  do- 
main,  and  a  smaller carboxy-terminai  domain positioned 
cytoplasmicaUy. The observation that KEX/cells intracellu- 
larly retain Kexlp activity prompted an analysis to determine 
in which secretory compartment Kexlp resided, and how it 
achieved such retention.  Kexlp was found to be localized to 
the yeast Golgi apparatus,  with retention  mediated via the 
cytoplasmic domain of the protein.  Removal of this domain 
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the protein to the vacuole rather than to the cell surface. This 
surprising result raises the possibility that the vacuole is the 
default destination  for yeast Golgi membrane proteins. 
Materials and Methods 
Strains, Growth Media, and Procedures 
Escherichia  coli strains and associated DNA manipulations were as de- 
scribed previously  (Cooper and Bussey,  1989). 
Saccharomyces cerevisiae strains c13ABYS86 ($86), Sc25k,  and Sc25k- 
13 (Sc25k  + kex/-A/) have been described previously (Cooper and Bussey, 
1989).  Other strains used were $6 (a strain sensitive to K1 killer toxin), 
TCI06cr (MATa leu2 his1 trpl ura3 [KIL-K1]), SEYS016a (secl-1 leu2 ura3 
gal20), XCY42-30D (MATa  ade2-10l ade X [a putative second ade mutation 
that results in white colonies] urn3 trpl lys2 leu2-3,H2 Amnnl::LEU2),  and 
LB2134-3B  (MATa mnng), mnn mutants were crossed with either Sc25 or 
Sc25-JH  (isogenic to Sc25k except MATa). The diploids were sporulated, 
asci dissected,  and spores containing the relevant mutations selected.  The 
resulting strains were HAB595 (mnn/ura3), HAB596 (ura3), and HAB597 
(mnn9 ura3). 
Growth media, yeast transformation, and gane disruption have all been 
described previously  (Cooper and Bussey,  1989). 
Restriction  endonucleases,  T4 DNA polymerase,  T4 DNA ligase,  and 
Klenow fragment were purchased from either Bethesda Research Laborato- 
ries, (Gaithersburg, MD) or New England Biolabs (Beverly, MA), and were 
used as recommended by the suppliers.  Unless otherwise stated, reagents 
used in these experiments were obtained from Sigma Chem. Co., St. Louis, 
MO. 
Disruption of the KEX1 Locus 
Disruption of the KEX/locus with the URA3-based construct pl6 resulted 
in the allele kexl-A2.  An alternative disruption using the LEU2-containing 
plasmid p17 produced the allele kex/-A3, p17 was constructed by digesting 
pl6 (Dmochowska et ai.,  1987) with EcoRV to remove the URA3 gene and 
a portion of the KEX/gene, and then replacing  it with an HpaI fragment 
carrying the LEU2 gene. p17 was cleaved with HindIII and used to transform 
the strains $86,  Sc25,  and TC106~  to $86-17, Sc25-17, and TC106~-17, 
respectively  (allele kexl-A3). 
Transformants were initially screened for a Kex- phenotype on the basis 
of the abolition of a K1 toxin killing zone for the transformants of Sc25k 
and TC106a, or on the basis of a smaller cr  zone for $86 
transformants.  Disruption of the KEX/locus was confirmed by Southern 
blot analysis (not shown). 
Site-directed Mutagenesis of  KEX1 
Mutagenesis  of the carboxy-terminal  region of KEXI was performed on the 
same single-stranded  DNA template and in the same manner as described 
(Cooper and Bussey, 1989). All of the mutations were confirmed by DNA 
sequencing (Sequenase,  United States Biochem. Corp., Cleveland, OH). 
Fig. 3 shows the extent of each of  the mutations listed below. Plasmid pKX1- 
18AMS contains KEX./with a precise deletion of the membrane-spanning 
domain (AMS) inserted into the multicopy plasmid pVT103-L (Cooper and 
Bussey,  1989). 
The aberrant stop mutation (AS) was identified while sequencing poten- 
tial AMS clones.  The AS clone contained a mutation at both bp1823 and 
bp1824, introducing a premature stop codon at codon 608. The Hpa muta- 
tion was to introduce an arginine residue immediately  after the membrane- 
spanning domain followed by a termination codon using the mutagenic oli- 
gonucleotide  5'  GGAGTTTATGCGTATCGTTAACGATAGAAGAGTGA 
3'. To aid in identifying mutant clones an HpaI site was introduced by the 
mntagenesis. All derivatives of the Hpa mutagenesis were subsequently se- 
quenced and found to have undergone a 2-bp deletion (A1908-1909 bp) up- 
stream from the inserted termination codon resulting in the mutation shown 
in Fig.  3. The Bcl mutation introduced a BclI cleavage site (5' GTTTAT- 
GCGTATGATTGATCAGTGAGGAGAAAAG 31  immediately  after  the 
aspartate residue (codon No. 637) which borders the carboxy-terminal por- 
tion of the membrane-spanning domain. The Hinc mutation introduced a 
termination codon 20 amino acid residues carboxy-terminal to the mem- 
brane-spanning domain using the mutagenic oligonucleotide  5' CCAAAT- 
AATAGTTAACATGACAGT 3'.  To  aid  in identifying  mutant clones an 
HinclI site was introduced by the mutagenesis.  Introduction of the various 
KEX/mutations into pVTI03-L  produced the following plasmids:  pKXI- 
18AS, pKXl-18Hpa,  pKXI-18Bel,  and pKXl-18Hinc. 
A 3.1-kb HindlH fragment containing the KEX/gene was inserted into 
YCpS0, which had been digested with HindlII, to give the plasmid pKXI- 
20WT. The 1.4-kb XhoI-HindlH fragment of pKXI-15 containing the vari- 
ous KEX/carboxy-terminal truncation mutations was isolated and ligated 
with the 1.7-kb HindlII-XhoI fragment containing the amino-terminal por- 
tion of  KEX/to reassemble the gene, and then inserted into HindlH-digested 
YCp50  to create pKX1-20AS, pKX1-20AMS,  pKXI-20Hpa,  and pKX1- 
20Hint. pAD81  (Dmochowska  et al.,  1987),  which contained the KEX/ 
gene, was digested with XhoI, the site was filled in with Klenow enzyme, 
and into this blunt-ended fragment was ligated the NheI nonsense codon 
linker 5' CTAGCTAGCTAG 3' (New England Biolabs). The resulting plas- 
mid contained stop codons in all three frames in KEX/at the XhoI site 
(+1760 bp). A 3.1-kb HindIIl fragment containing the mutation at the XhoI 
site was then inserted into HindlH-digested  YCp50 to create pKX1-20Xho. 
YCp50-CT2 contains the ADH/promoter and multiple cloning site from 
the plasmid pVT-100-L (Veruet et al., 1987) cloned into the plnsmid YCpS0. 
The termini of the 3.0-kb BgllI-HindIII fragment of KEX/were filled with 
Klenow  enzyme and inserted into YCp50-CT2  which had been digested 
with Pvull. The resulting plasmid, pKXI-24,  results in an ~10-fold over- 
production of Kexlp. 
The various truncation  mutations of  KEX/were placed downstream from 
the GAL/promotor in plasmid pMB258 to create the following plasmids: 
pKX1-25WT, pKX1-25Hpa,  pKX1-25Bcl, and pKX1-25Hinc. 
Immunoprecipitations and Carbonate Extractions 
Antisera production and procedures for sodium carbonate extractions,  ra- 
diolabeling ceils, and associated immunoprecipitations  have been described 
previously  (Cooper and Bussey,  1989). 
Labeling of Spheroplasted Cells 
$86-16 transformants were grown to mid-log, and 6  ￿  l0  s cells harvested, 
washed in I"I20, and resuspended in 3 ml of ZSM (1.2 M sorbitol, 10 mM 
CaC12, 10 mM Tris-HC1, pH 7.5). 300/~g of Zymolyase 60,000 (ICN Bio- 
medicals,  Inc., Costa Mesa, CA) and/~-mercaptcethanol (final concentra- 
tion 0.4%) were added to the cells before incubation at 30oc for 75 min. 
The resulting spheroplasts were gently pelleted, washed twice in 1.2 M sor- 
bitol, 10 mM Tris-HC1 (pH Z5), and resuspended in 25 ml of YNB-Sorb 
(Yeast Nitrogen Base, 2% glucose,  1.2 M sorbitol), and incubated at 30oc 
for 3 h. Spheroplasts  were then concentrated to 5 ml, and BSA (200 mg 
ml  -l) and PMSF (Boehringer Mannheim Corp., Indianapolis, IN; final con- 
centration I raM) were added before the addition of 500 mCi of Tram Label 
(ICN Biomedicals,  Inc.). After 10 rain, half of the cells were harvested and 
the remainder chased for 30 rain as described above. After labeling, the 
spheroplasts  were placed on ice, and sodium azide (Fisher Scientific Co., 
Pittsburgh, PA) was added to 1 raM. Spheroplasts were then gently pelleted 
and both the supernatant and pellet fractions retained. The supernatant was 
microfuged  for 2 rain and the resulting supernatant was concentrated with 
Centricon 30 (Amicon, Beverly, MA) to a final volume of 200 ~tl before 
heating to 100~  in the presence  of SDS (1%). The spheroplasts werv washed 
once in ice cold 1.2 M sorbitol, I0 mM Tris-HC1 (pH 7.5), pelleted, resus- 
pended in BSB +  1% SDS (Cooper and Bussey,  1989), and boiled. The 
detergent-solubilized samples were then treated as above and immum~recipi- 
tated with Kexlp antiserum. 
Affinity Purification of  Kexlp Antibodies and Indirect 
Immunofluorescence Studies 
fl-Galactosidase-Kexlp  fusion protein (Cooper and Bussey, 1989) was iso- 
lated by preparative SDS-PAGE; electmeluted into 0.I M NI-~CO3, 0.1% 
SDS;  lyophilised;  resuspended in coupling buffer (0.5  M  NaCl,  0.1  M 
NaHCO3, pH 9.0); and then dialyzed against coupling buffer + 0.25% SDS 
+  80 mg ml  -~ PMSF.  The extract was then coupled to 2 g of activated 
CNBr-Sepharose 413 (Pharmacia LKB Biotechnology  Inc., Piscataway, NJ) 
overnight at room temperature.  The coupling efficiency was judged to be 
> 80 % as determined by comparing unbound protein with the stming material. 
The Sepharose was incubated with blocking buffer (1 M ethanolamine, 0.1 
M NaHCO3, pH 8.0, 0.5 M NaCI) for 4 h at room temperature.  The result- 
ing column (bed volume, 2 ml) was then treated with successive washes of 
coupling buffer and acetate buffer (0.1 M sodium acetate, pH 4.0, 0.5 M 
NaC1), and finally with PBS. A similar column (bed volume, 2 ml) was made 
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tosidase. 
Both the/~-galactosidase  and ~-galactosidase-Kexlp  columns were washed 
successively with buffer A (50 mM Hepes, pH 7.5,  150 mM NaCI,  1 mM 
EDTA), buffer B (buffer A  +  1 M guanidine-HC1), and buffer C (50 mM 
Hepes, pH Z5, 15 mM NaC1, 4.5 M MgCI2).  The two columns were then 
arranged so that the eluate from the #-galactosidase column flowed into the 
/~-galactosidase-Kexlp  column. All buffers used from this point on contained 
in addition:  1 mg/ml  -I BSA, 0.2%  NAN3, 1 mM PMSE  Columns were 
equilibrated with buffer A; Kexlp antiserum was loaded onto the linked 
columns and was circulated for 3 h at 4~  The columns were disconnected 
and the O-galactosidase-Kexlp column was washed first with buffer B and 
then with buffer A. Antibodies were then eluted from this column with buffer 
C; fractions were collected and immediately dialyzed against buffer A at 
40C. Eluted fractions were tested for the presence of antibodies with a dot- 
blot Western approach and the positive fractions tested for their ability to 
immnnoprecipitate [35S]methionine-labeled Kexlp from yeast. These frac- 
tions were concentrated by dialysis against buffer A containing 15% glyc- 
erol, and stored at  -70~ 
Immunofluorescence studies were performed following the procedure of 
Redding et al. (1991) and used either affinity-purified anti-Kexlp antibodies 
or a mouse monoclonal (13D11) which is directed against the 60-kD subunit 
of the yeast vacuolar membrane H+-ATPase (Kane et al., 1992).  The cells 
were observed using an Axiophot microscope (Carl  Zeiss, Inc., Thorn- 
wood, NY) (equipped for epifluorescence at excitation wavelengths appro- 
priate for the described fluors) with a  100X objective and photographed 
with T-Max 400 film (Eastman Kodak Co., Rochester, NY). Mitochondria 
and nuclei were identified  by 4',6-diamidino-2-phenyl-indole  staining while 
vacuoles were identified by differential interference contrast (Nomarski) 
optics. 
Results 
KeMp Is Glycosylated within the Golgi Apparatus 
Upon translocation into the yeast ER, proteins that are des- 
tined for Asn-linked glycosylation receive a core oligosac- 
charide which can be elaborated in the Golgi apparatus by 
the  addition  of further mannose  residues  to produce the 
"outer chain:  The outer chain consists of a  backbone of 
u(1--~6) linked mannose residues to which are attached man- 
nose sidechains in ot(l~2) linkages which then terminate in 
c~(1---3) linkages (Fig. 1; Ballou, 1982). The extension of the 
core is heterogenous in nature with different proteins receiv- 
ing varying degrees of elaboration. 
Kexlp  is  a  glycoprotein  which  receives  Asn-linked 
glycosylation in a  multistep process (Cooper and Bussey, 
1989).  The  initial  event  occurs  in  the  ER  where  core 
oligosaccharides are attached to the protein. The observed 
difference in molecular mass of ~ 3-4 kD between Kexlp la- 
beled for 10 min and that of Kexlp produced in tunicamycin- 
treated cells suggests that two of the three predicted lumenal 
Asn acceptor residues are glycosylated. The Ash-linked core 
oligosaccharides undergo a modification in a post-ER com- 
partment that increases the mass of  Kexlp by 1-2 kD, demon- 
strating that Kexlp does not receive an extensive outer chain 
(Cooper and Bussey,  1989).  Such a  modification was  re- 
duced in a secl mutant which blocks intra-Golgi transport, 
and was unaffected in a secl mutant that prevents secretory 
vesicle fusion with the plasma membrane (Novick et al., 
1981; Cooper and Bussey,  1989). 
The yeast Golgi apparatus has been functionally subdi- 
vided into several compartments on the basis of Asn-linked 
oligosaccharide addition (Franzusoff and Schekman,  1989; 
Graham and Emr,  1991).  Glycoproteins receive mannose 
outer chain modifications while traversing these Golgi com- 
partments. Identification of the enzymes responsible for the 
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Figure L Schematic outline of outer chain glycosylation mutants. 
mnn mutants are shown in the context of the mannose residues 
missing  in  each  mutant.  Arrows  represent  either  fl'2)-c~-D, 
(1--'3)-t~-D, or (1--'6)-ot-D linkages between mannose residues. 
*  indicates  predicted  marmose residues  attached  to  the  core 
oligosaccharide of Kexlp in a post-sec18, pre-sec7  manner. --j, in- 
dicates mannose residues absent in an mn,d strain. Circled M indi- 
cates predicted mannose residues added to Kexlp in an MNN1- 
dependent manner (adapted from Lewis, M. J., and C. E. Batlou. 
1991. J. Biol. Chem. 266:8255-8261). 
post-ER modification(s) may indicate to which Golgi com- 
partments  Kexlp has  been  exposed,  and  thereby localize 
Kexlp within the secretory pathway. The basis of  the post-ER 
progressive carbohydrate modification of Kexlp was  ana- 
lyzed using strains with mutations at various mnn loci. Such 
mutant strains show defects in outer chain glycosyl elabora- 
tion resulting in various truncations of the outer chain (Bal- 
lou, 1982; Kukuruzinska et al.,  1987; Fig.  1). Several mnn 
strains were radiolabeled and the degree of modification of 
immunoprecipitated Kexlp was examined. Kexlp produced 
in mnn9 ceils received most, if not all, of the wild-type gly- 
cosyl modification (Fig.  2, lanes 5  and 6) suggesting that 
most of the carbohydrate addition to Kexlp was not in the 
elaboration of the outer chain as mnn9 blocks initiation of 
outer chain synthesis (Ballou,  1982; Kukuruzinska et al., 
1987). A likely candidate for the mnn9-independent  modifi- 
cation was the Golgi-localized ~(1 ~3) mannosyltransferase 
which has been shown to be responsible for t~(l~3) man- 
nose addition to both the core and outer chains (Fig, 1; Naka- 
jima and Ballou,  1975;  Franzusoff and  Schekman,  1989; 
Graham and  Emr,  1991).  This enzyme activity has  been 
found to be deficient in an mnnl strain, and Kexlp synthe- 
sized in a strain disrupted at the mnnl locus received only 
a small modification of  its core oligosaccharide (Fig. 2, lanes 
3 and 4). The ot(l~3) mannosyltransferase is therefore re- 
sponsible for producing the majority of the post-ER glyco- 
sylation modification to Kexlp. 
Carboxy-terrainal Truncations of  Kexlp 
The modification of Kexlp by the Golgi ot(l~3) mannosyl- 
transferase suggested that Kexlp reached the Golgi compart- 
ment containing the mannosyltransferase, yet little Kexlp- 
dependent activity was detected at the cell surface (see be- 
low) and indicated that Kexlp was retained within the secre- 
tory pathway. 
An analysis of mutant forms of Kexlp was undertaken to 
examine which domain(s) of Kexlp was responsible for its 
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(WT), HAB595 (mnnl), and HAB597 (mnng) transformed with 
pKX1-24, underwent a 10-min radiolabeling pulse and were either 
harvested (P) or chased (C) for an additional 60 rain. Kexlp was 
then immunoprecipitated and analyzed by SDS-PAGE and fluorog- 
raphy. 
retention. The hydrophobic domain near the carboxy termi- 
nus of  Kexlp was previously shown to be responsible for con- 
ferring membrane association, as deletion of this 17-amino 
acid residue region resulted in a soluble protein, Kexlp-AMS 
(Cooper and  Bussey,  1989).  Cells expressing this protein 
showed a significant increase in Kexlp-dependent activity in 
the cell medium (see below). That Kexlp-AMS was secreted 
rather than retained suggests that one of  several domains may 
be responsible for retention of Kexlp:  (1) the membrane- 
spanning domain which was absent in Kexlp-AMS, (2) the 
carboxy-terminal domain which was no longer exposed in 
the  cytoplasm in  Kexlp-AMS,  and  (3)  a  domain  amino- 
Figure 3. The predicted truncated forms of Kexlp. A schematic de- 
piction is shown of the predicted truncated forms of Kexlp using 
the single-letter amino acid code. The asterisks denote the position 
of a termination codon and the dashes in Kexlp-AMS represent the 
precise deletion of  the membrane-spanning domain. The circled Gs 
denote the potential sites for Asn-linked glycosylation on the lu- 
minally exposed domain of Kexlp. The gray shaded regions repre- 
sent portions of Kexlp with homology to yeast CPY. 
Figure 4. Glycosylation and membrane association of Kexlp-Hpa. 
S86-16/pKXl-18Hpa was radiolabeled for a 10-min pulse (P) and 
harvested or chased for an additional 90 min (C). Tunicamycin 
treatment (TCM) and high pH sodium carbonate extraction were 
performed as described previously (Cooper and Bussey, 1989). The 
forms of Kexlp were immunoprecipitated and analyzed by SDS- 
PAGE and fluorography. 
terminal to the membrane-spanning domain which is per- 
turbed in Kexlp-AMS when the cytoplasmic domain was jux- 
taposed adjacent to it. 
A number of carboxy-terminal truncations of Kexlp were 
produced to test the above possibilities. The construction of 
these mutations via site-specific mutagenesis or nonsense 
linker insertion is described in Materials and Methods and 
the predicted proteins are shown in Fig. 3. Immunoprecipita- 
tions of the mutant Kexlp proteins were performed to con- 
firm that they were correctly synthesized by the cell (Fig. 4). 
All of the truncated proteins were smaller than Kexlp by 
the predicted amount and entered the secretory pathway as 
shown by the addition of Ash-linked glycosylation (data not 
shown). A concern was that the mutants designed to remain 
membrane associated may not attain a stable type I orienta- 
tion and remain in the ER. The most severely truncated mu- 
tant in this class, Kexlp-Hpa, lacks the entire endogenous cy- 
toplasmic domain;  it was  further analyzed and  shown to 
receive Asn-linked glycosylation  which was further modified 
within the Golgi apparatus (Fig. 4).  Previous sodium car- 
bonate extractions of whole cell extracts demonstrated that 
Kexlp  fractionated  with  the  membrane  containing  pellet 
fraction whereas the soluble protein, Kexlp-AMS, fraction- 
ated with the supernatant (Cooper and Bussey, 1989). Car- 
bonate treatment of whole cell extracts showed that Kexlp- 
Hpa fractionated with the membrane pellet (Fig. 4, lanes 5 
and 6), consistent with it being an integral membrane pro- 
tein. In addition, we have shown that CPY, a soluble Kexlp- 
like protein, is fully soluble under these extraction condi- 
tions (data not shown). 
Soluble Forms of  Kexlp Are Secreted 
to the Cell Surface 
Kexlp activity was assayed in whole cells and their growth 
media to detect any potential mislocalization of  the truncated 
forms of Kexlp to the cell surface. To compare mutants, it 
was important that the KEX/gene copy number be constant. 
The Kexlp truncation constructs were,  therefore, inserted 
into the vector YCp50,  a centromeric-based plasmid which 
is normally maintained at a single copy per cell (Rose et al., 
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Strain  Activity in the medium  Activity in the periplasm  Intracellular activity  Total activity 
% of Total activity  Units~Optical Density 
A.  $86  4.8  1.2  94  4.3 
$86-17  0  0  0  0 
$86-17/Xho  72  9  19  0.45 
$86-17/AS  67  8  25  0.57 
$86-17/AMS  70  8  22  0.6 
$86-17/Hpa  7  3  90  0.65 
$86-17/Hine  1.9  5.1  93  0.49 
$86-17/WT  3.5  3.5  93  0.44 
B.  $86  9.5  4.4  86  1.6 
$86/GAL-KEX1  4  10  86  110 
The indicated strains and transformants were inoculated in either YEPD (A) or YEP +  galaetose (B) to a high cell density and grown to stationary phase. The 
intact cells were washed twice in water and a portion were lysed in 50 mM succinic acid (pH 6.0) with glass beads. The growth media, whole cells, and lysed 
cells were then assayed for Kexlp activity as described (Cooper and Bussey, 1989).  A unit is defined as 1 pmol of product produced per minute at 30"C. (Error 
-I- 5%.) 
1987).  Construction of these plasmids resulted in the dele- 
tion of  an upstream portion of  the K/Ds  This dele- 
tion resulted in reduced production of the encoded proteins 
relative to wild-type levels. These constructs (the pKX1-20 
series of plasmids) were transformed into the yeast strain 
$86-17 (kex/-A3), a derivative ofS86 in which the KEX/gene 
had been disrupted. The transformants were grown in liquid 
selective media; and the media, whole cells, and solubilized 
lysed cells were assayed for Kexlp activity (data not shown). 
$86-17  produced no activity and the plasmid-borne wild- 
type KEX/gene partially restored activity (10% of the level 
produced by the genomic allele of KEX/) consistent with the 
promoter truncation. 
In comparing the partitioning of Kexlp activity from vari- 
ous truncation mutants with that of the wild-type, two sepa- 
rate groups became apparent.  The Kexlp-Hpa and Kexlp- 
Hinc  truncated  proteins  (those  that  remained  membrane 
associated; Fig. 3) showed the same partitioning pattern as 
that of wild-type, whereas the proteins Kexlp-Xho, -AS, and 
-AMS (soluble proteins lacking the membrane-spanning do- 
main) formed a different pattern with a  10-fold increase in 
activity at the cell surface relative to that of wild type. The 
total activity of each protein was approximately constant 
within a group. Kexlp-Hpa and Kexlp-Hinc had a total activ- 
ity similar to that of wild type while the soluble forms of 
Kexlp had ~50%  of wild-type activity. Although the de- 
crease in activity may have been a direct consequence of the 
mutations, it was also possible that the reduced activity was 
due to secretion and subsequent degradation of  the truncated 
soluble proteins. If such degradation of the soluble forms of 
Kexlp-Xho, -AS, and -AMS was occurring external to the 
plasma membrane, then the addition of BSA to the growth 
medium may lessen the extent of degradation. The addition 
of relatively high levels of BSA did not, however,  alter the 
levels of total activity for Kexlp-Xho, -AS, and -AMS. 
A  different approach to reduce potential degradation of 
truncated forms of Kexlp was taken where transformants 
were  grown in selective conditions (minimal media)  and 
then transferred to nonselective YEPD  media for several 
generations before assay.  YEPD, a medium consisting pri- 
marily of yeast extract and peptone, should provide a sub- 
strate  "buffer" against  proteolytic  degradation.  Although 
transformants were grown temporarily under nonselective 
conditions, plasmid loss was never >2% (data not shown). 
Activity partitioning data suggested that Kexlp-Xho, -AS, 
and -AMS were secreted from the cell while the other con- 
structs (Kexlp, Kexlp-Hpa, and Kexlp-Hinc) remained intra- 
cellular (Table I). All the mutant forms of Kexlp had approx- 
imately the same total activity as the plasmid-borne wild 
type. The percentage of Kexlp extracellular activity for the 
membrane-associated forms of  Kexlp was comparable to the 
percentage of cells that stained positively with the vital dye 
methylene blue,  suggesting that such extracellular activity 
resulted from cell lysis. KEX/was placed downstream from 
the GAL/ promoter which,  upon induction by growth on 
galactose, resulted in a  70-fold increase over endogenous 
Kexlp activity. However,  such overproduction did not in- 
crease the percentage of extracellular Kexlp activity relative 
to wild-type levels  (Table I). 
To  demonstrate  the  secretion  of the  soluble  forms  of 
Kexlp,  $86-16  (kex/-A2)  was  transformed  with  pKX1-8 
(Kexlp) or pKXI-18AMS  (Kexlp-AMS), and cells were then 
spheroplasted. The spheroplasts were radiolabeled (10 min), 
chased (30 min), and solubilized with SDS, and Kexlp was 
immunoprecipitated. Media, containing proteins exported 
Figure 5. Mislocalization  of Kexlp-AMS to the periplasm. $86-16/ 
pKX1-8 (Kcxlp-WT) or S86-16/pKXl-18AMS (Kexlp-AMS) were 
spheroplasted and then radiolabeled for a 10-min pulse (P). Half 
of the spheroplasts and media were harvested while the remainder 
was chased for an additional 30 min before harvest. The forms of 
Kexlp were immunoprecipitated from both  the media and the 
spheroplasts and analyzed by SDS-PAGE  and fluorography.  The ar- 
row indicates the full length Kexlp-AMS. 
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was  immunoprecipitated.  Wild-type  Kexlp  remained  as- 
sociated  with  the  spheroplasts,  whereas  Kexlp-AMS  was 
shown to be secreted from the cell; the Kexlp-AMS signal 
associated with the cell fraction diminished with time while 
the signal from the medium showed the reverse trend (Fig. 
5).  Thus, the results of the pulse-chase analysis correlated 
with the activity data and indicated that Kexlp-AMS, a solu- 
ble form of Kexlp, was  secreted from the cell. 
The Effect of Carboxy-terminal Truncations of  Kexlp 
upon KI Killer Toxin Processing 
A stringent test of the effect of the truncations of Kexlp was 
to determine the ability of the mutant proteins to carry out 
the Golgi-based proteolytic processing of K1 killer toxin in 
vivo (for review see Bussey, 1988). Sc25k is a strain harbor- 
ing  the  dsRNA  virus  that  encodes  K1  killer  toxin,  and 
produces a killing zone on plates seeded with a strain sensi- 
tive to the killer toxin (Bussey et al.,  1983). The pKX1-20 
series  of plasmids  (centromeric based)  were transformed 
into Sc25k-13 (kex/-A/), and the transformants analyzed for 
their ability to process K1 killer toxin and produce a killing 
zone (Fig. 6 A). Sc25k-13 containing the vector plasmid pro- 
duced no killing zone, whereas the introduction of  a plasmid- 
based copy ofKEXI (pKX1-20WT) enabled the strain to pro- 
duce active K1 killer toxin as shown by the appearance of a 
zone (Fig. 6 B). This zone was smaller than that of Sc25k 
(KEXI) because of the KEX/promoter truncation in pKX1- 
20WT (discussed above). The truncated forms of  Kexlp, both 
soluble  and  membrane  associated,  produced killer  zones 
significantly  smaller  than  that  produced  by  pKX1-20WT 
(Fig. 6 A). This functional complementation assay was also 
conducted in a  different K1  killer strain (TC106ot-17) with 
similar results. 
The reduced processing of K1 killer toxin by the soluble 
forms of Kexlp can be explained because of their secretion 
and consequent reduced concentration of Kexlp within the 
processing  compartment.  The membrane-associated trun- 
cated forms of Kexlp remain intracellular and,  therefore, 
secretion cannot account for their reduced processing ability. 
The above results indicated that Kexlp-Hpa was membrane 
associated, had received glycosyl modifications in the Golgi 
apparatus, gave wild-type levels of total activity, and was re- 
tained  intracellularly;  yet  processed  the  K1  killer  toxin 
precursor  to  a  lesser  extent  than  Kexlp.  Kexlp-Bcl  and 
Kexlp-Hinc showed  similar  phenotypes to  that of Kexlp- 
Hpa.  A  likely explanation for such observations was  that 
these membrane-associated mutant forms of Kexlp were not 
retained within the correct Golgi compartment, but instead 
were mislocalized within the secretory pathway. 
Kexlp Resides in the Yeast Golgi Apparatus While 
Membrane-associated Mutant Forms Are Mislocalized 
to the Vacuolar Membrane 
Indirect immunofluorescent detection of Kexlp and Kexlp- 
Hpa was undertaken to determine if the location of the two 
proteins differed. The expression of the proteins was such 
that a Kexlp signal could only be detected upon overproduc- 
tion of Kexlp (Fig. 7). Kexlp was found to be localized to 
a number of small punctate structures (on average, ,x,3-5 per 
cell) which were not associated with mitochondria, nuclei, 
or vacuoles, but were characteristic of proteins localized to 
Figure 6. Production of  active KI killer toxin by the truncated forms 
of Kexlp. (A) Left column shows five different transformants of 
Sc25k-13 with pKX1-20WT. Right column shows Sc25k-13 trans- 
formed with one of the following plasmids: pKXI-20-Xho (Xho), 
pKXI-20-AS (AS), pKX1-20-AMS (AMS), pKX1-20-Hpa  (Hpa), or 
pKX1-20-Hinc (Hinc). Transformants were grown to  stationary 
phase in minimal media, harvested by centrifugation, washed in 
H20, pelleted, and than resusponded in H20 to a concentration of 
5  x  108 cells ml  -~.  10/~1 was then placed onto a minimal plate 
(pH 4.7),  seeded with $6 (a strain sensitive to K1 killer toxin). 
Plates were then incubated at 18"C for 24 h and zones of toxin kill- 
ing examined. Approximate relative toxin activities, determined by 
comparison with a toxin dilution series were WT 100%, Xho 30%, 
AS 40%,  AMS  15%, Hpa 55%,  and Hinc 55%.  (B)  Sc25k-13 
(kex/),  Sc25k  (KEX1), and  Sc25k-13/pKXI-20WT (WT) were 
grown and spotted onto a plate seeded with a strain sensitive to K1 
killer toxin and treated as described above. 
the yeast Golgi apparatus (Redding et al., 1991; Cleves et al., 
1991; Franzusoff et al.,  1991; Roberts et al.,  1992). 
Comparison of the Kexlp-Hpa localization with that of the 
vacuole (as determined by Nomarski optics) indicated that 
almost all of  Kexlp-Hpa was in the vacuole (data not shown). 
It is likely that Kexlp-Hpa was transported to the vacuole, 
where, in a protease-deficient strain such as $86-16, the pro- 
tein was not degraded and remained active. 
To confirm this possibility, colocalization studies were un- 
dertaken between the  60-kD  subunit  of the S.  cerevisiae 
vacuolar membrane H§  and either Kexlp or Kexlp- 
Hpa. The vacuole (as determined by Nomarski optics) cor- 
related to the ring  structure in  which the 60-kD  ATPase 
subunit was localized by indirect immunofluorescence. The 
level of  Kexlp detected varied among cells due to the variable 
plasmid copy number (2 #m based). Observation of cells ex- 
pressing both low and high levels of Kexlp-Hpa (as deter- 
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Kexlp in S. cerevisiae. S86-16/pKXI-18Hpa  (Kexl-Hpa) ceils were 
prepared as described in Fig.  7 above and viewed under FITC 
(which indicates the position of the 60-kD subunit of the vacuolar 
membrane H§  and Texas red (which indicates the posi- 
tion of Kexlp-Hpa) excitation wavelengths. 
Figure 7. Indirect immunofluorescence  detection of  Kexlp in S. cere- 
visiae. S86-16/pVT103-L  (kexl-A), and S86-16/pKX1-8 (Kexl-WT) 
were prepared for immunofluorescence as described in Materials 
and Methods. The cells were viewed by Nomarski differential inter- 
ference optics, and under 4',6-diamidino-2-phenyl-indole  (indicates 
the position of the nucleus and mitochondria), FITC (indicates the 
position of the 60-kD subunit of the vacuolar ATPase), and Texas 
red (indicates the position of Kexlp) excitation wavelengths. 
mined by the intensity of the fluorescence) indicated that 
>90% of  the protein was located in the vacuole. A small per- 
centage of cells (<5 %) showed both ER and vacuolar stain- 
ing. The protein was associated with the vacuolar membrane 
demonstrating that it remained membrane associated (Fig. 
8).  Kexlp was predominantly restricted to punctate struc- 
tures indicative of a yeast Golgi location (Fig. 7). However, 
10-15 % of the stained cells expressed high levels of Kexlp 
(as  determined by the  intensity of the  fluorescence) and 
showed Kexlp in both Golgi-like structures, and associated 
with the vacuolar membrane as defined by the 60-kD ATPase 
subunit (data not shown). No Kexlp or Kexlp-Hpa signal was 
detected  at  the  plasma  membrane.  Further  indirect  im- 
munofluorescence analysis also  localized the  other mem- 
brane-associated forms, Kexlp-Bcl and Kexlp-Hinc, to the 
vacuolar membrane (data not shown). 
Discussion 
Kerdp Resides in the Yeast Golgi Apparatus 
An analysis of the oligosaccharide modification of Kexlp in- 
dicated secretory compartments to which the protein had 
been exposed, and the likely subcellular location of Kexlp. 
The modification of the Asn-linkod oligosaccharide cores of 
Kexlp occurred within the Golgi apparatus  and likely in- 
volves several sequential steps. Initially, in a pre-sec7 com- 
partment, the core oligosaccharides are partially modified as 
judged by an increase in apparent molecular mass (Cooper 
and Bussey,  1989).  Subsequently, in a  post-sec7  compart- 
ment,  the  core is  further modified in  a  MNNl-dependent 
manner.  Invertase produced in sec7 cells at the restrictive 
temperature  does  not  receive  c~(1--'3) linked  mannose 
residues to the core or outer chain (Franzusoff and Schek- 
man,  1989), most likely because of the failure of secretory 
proteins to reach the compartment containing the cx(1--,3) 
mannosyltransferase. It is consistent that sec7 and mnnl mu- 
tations  result in  a  similar  reduction in  the  glycosyl elab- 
oration  of Kexlp,  as  they  would  respectively either  pre- 
vent Kexlp from reaching,  or  reduce the activity of,  the 
c~(1~3) mannosyltransferase. The Golgi-based modification 
of Kexlp can thus be explained as a result of two processes. 
The first occurs before the sec7 block and most likely in- 
volves the addition of an ot(l~6) mannose residue followed 
by the attachment of an oz(1--'2) linked mannose residue (in- 
dicated by * in Fig.  1). The second step involves the MNN1- 
dependent addition of up to three a(l'3)  linked mannose 
residues (indicated by a circle in Fig.  1) to the oligosaccha- 
ride (Ballou et al.,  1990). 
Graham and  Emr (1991) provided evidence for at least 
three functional compartments in the yeast Golgi apparatus 
that contain, from cis to trans,  the following activities: (1) 
ct(l~6) mannosyltransferase, (2) cx(l~3) mannosyltransfer- 
ase, and (3) Kex2p endoprotease. Kexlp must reach the Golgi 
compartment housing  the MNNl-dependent  o~(1---3) man- 
nosyltransferase as it is modified by this enzyme. In addition, 
to process killer toxin, Kexlp must reach the proposed third 
Golgi compartment containing Kex2p as the toxin precursor 
substrate for Kexlp is created by a  Kex2p-mediated endo- 
proteolytic cleavage.  No  post-Kex2p compartment before 
secretory vesicles has been observed (Graham and  Emr, 
1991)  and,  therefore,  it  is  likely  that  Kexlp resides  with 
Kex2p in the same late Golgi compartment (Redding et al., 
1991).  It is interesting to note that both Kexlp and Kex2p 
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pathway. A model for the retention of Kexlp is presented. Kexlp is 
retained in a late Golgi compartment  because of its cytoplasmically 
exposed domain interacting with a receptor (Recpt). Kexlp-AS,  be- 
ing soluble, is secreted by default to the cell surface. Kexlp-Hpa is 
membrane associated  and residues in the vacuole  because of  several 
possible reasons: (1) Kexlp-Hpa is partially misfolded and is tar- 
geted to the vacuole via an unknown system; (2) the membrane- 
spanning domain of Kexlp contains a cryptic targeting signal for 
the vacuole; (3) Kexlp-Hpa is secreted to the plasma membrane 
where it is endocytosed and delivered  to the vacuole; and (4) mem- 
brane-associated proteins that  leave the  Golgi  apparatus are 
targeted to the vacuole  by default. Kexlp is delivered to the vacuole 
when overproduced to a high level, presumably due to saturation 
of a Golgi retention receptor. The horizontal bar protruding from 
the Kexlp-WT box represents the membrane-spanning and cyto- 
plasmic domain, while for Kexlp-Hpa  the bar represents the mem- 
brane-sparming domain. 
(Wilcox and Fuller, 1991) undergo a slow addition ofa(l~3) 
mannose units to their respective glycosyl groups. 
Further evidence that Kexlp is an enzyme that resides in 
the yeast Golgi apparatus comes from indirect immunofluo- 
rescence results where a punctate pattern of staining is de- 
tected that is characteristic for a number of  proteins localized 
to the Golgi apparatus in S. cerevisiae: Kex2p (Redding et 
al.,  1991), DPAP A (Roberts et al.,  1992),  Secl4p (Cleves 
et al., 1991), and Sec7p (Franzusoff et al.,  1991). 
The Cytoplasmic  Domain of  KeMp Confers Retention 
in the Golgi Apparatus 
Of the mutations that result in a  soluble form of Kexlp 
(Kexlp-Xho, -AS, and -AMS), Kexlp-AS is the most inform- 
ative with regard to determining which domain(s) of Kexlp 
is involved in its localization. Kexlp-AS is secreted, yet con- 
tains all but 11 residues of the 596-residue lumenal domain 
(Fig. 3). The 11 residues absent in Kexlp-AS are present in 
Kexlp-AMS which is also secreted. The results suggest that 
either the membrane-spanning or cytoplasmic domain, or 
both, are responsible for the retention of Kexlp within the 
Golgi apparatus. 
Kexlp-Hpa contains both the lumenal and transmembrane 
domains of Kexlp yet is mislocalized to the vacuolar mem- 
brane. Similar results were found for Kexlp-Bcl and Kexlp- 
Hinc which lack all or part of the cytoplasmic domain and 
strongly implicate this domain of KeMp as being necessary 
for correct localization within the Golgi apparatus. 
Previous work has demonstrated the role that cytoplasmic 
domains of transmembrane proteins play in the retention and 
targeting of proteins within the secretory pathway.  A con- 
sensus retention motif has been identified at the termini of 
the cytoplasmically  exposed domain of mammalian ER resi- 
dent type I transmembrane proteins (Nilsson et al.,  1989; 
Jackson et al., 1990). The cytoplasmic domains of the trans- 
ferrin  receptor,  cation-independent mannose-6-phosphate 
receptor, and the lysosomal acid phosphatase are involved in 
the correct targeting or endocytosis of these proteins (Roth- 
enberger et al., 1987; Lobel et al., 1989; Peters et al., 1990). 
The three proteins involved in processing a-factor, KeMp, 
Kex2p, and DPAP A, are all transmembrane proteins with 
cytoplasmic domains which are thought to be involved in 
retention of the respective proteins in similar if not identical 
compartments of the yeast Golgi apparatus (Fuller et al., 
1989; Roberts et al., 1992). Attempts to identify a consensus 
yeast Golgi retention motif shared between these proteins 
have, however, showed no obvious amino acid sequence ho- 
mology between the cytoplasmic domains of  these three pro- 
teins. 
Retention of  Merabrane Proteins 
in the Golgi Apparatus 
Different mechanisms have been proposed for the retention 
of proteins within Golgi compartments. Interactions involv- 
ing the cytoplasmic domain of Kexlp may result in the aggre- 
gation of the protein in the appropriate compartment, and 
thereby prevent it from entering transport vesicles that are 
exiting the Golgi compartment (Pfeffer and Rothman, 1987). 
This retention via aggregation model is unlikely as it does 
not explain why aggregation would not occur earlier in the 
secretory pathway or why overproduction of a Kexlp results 
in mislocalization to the vacuole rather than greater aggrega- 
tion in the Golgi compartment. A more likely explanation for 
the retention involves  a receptor interacting with the cyto- 
plasmically exposed domain of  Kexlp (Fig. 9). High level ex- 
pression of  Kexlp would saturate the receptor with the result 
that excess Kexlp is diverted to the vacuole. Removal of the 
cytoplasmic domain would abolish such a receptor-ligand 
interaction, also resulting in mislocalization to the vacuole. 
Retention of soluble ER proteins has been shown to involve 
a  receptor-mediated retrieval of proteins  from a  pre-cis- 
Golgi compartment (Semenz~ et al.,  1990;  Lewis et al., 
1990).  A cytoplasmicaUy based retrieval system analogous 
to the ER system can be envisaged in which Kexlp is re- 
trieved  from  a  trans compartment,  possibly  the  plasma 
membrane, and returned to the correct Golgi compartment. 
To determine if Kexlp is retrieved from the plasma mem- 
brane an immunofluorescence  experiment was performed by 
inducing expression of Kexlp in a secl strain, secl is a condi- 
tional mutation that, at the nonpermissive temperature, pre- 
vents the fusion of secretory vesicles with the plasma mem- 
brane (Novick et al.,  1981). The delivery of Kexlp to its 
Golgi location was not blocked by secl, and if KEX/expres- 
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staining pattern of Kexlp was not altered even after 3 h at the 
restrictive  temperature  (data  not shown).  Therefore,  if a 
receptor retrieval  system exists, it is unlikely  that Kexlp is 
retrieved  from the plasma membrane as outlined in one of 
several proposals presented by Payne and Schekman (1989). 
If a retrieval system is responsible for the retention of Kexlp, 
then the salvage compartment may instead be located be- 
tween the Golgi compartment and the vacuole where failure 
to bind the receptor would result in delivery to the vacuole. 
Alternatively,  the receptor may remain anchored within 
the Golgi  apparatus  and  not recycle.  The  clathrin  heavy 
chain has been implicated  in the retention  of Kex2p (Payne 
and Schekman, 1989), raising the possibility that the recep- 
tor-based system that recognizes the cytoplasmic domain of 
Kexlp, and potentially Kex2p and DPAP A, might be one of 
the clathrin-associated  adaptin  proteins known to occur in 
yeast (Kirchhausen,  1990). 
Default Targeting of Yeast Membrane Proteins 
to the Vacuole 
Truncated forms of Kexlp which lacked the cytoplasmic do- 
main yet still remained membrane associated were not re- 
tained in the correct Golgi compartment,  and even at subwild- 
type expression levels v~ere diverted to the vacuole. Similar 
mislocalization  results have been found with DPAP A, where 
overexpression of the protein results in mislocalization to the 
vacuole, as do mutations within its cytoplasmically exposed 
domain (Roberts et al.,  1992).  Differing  results were ob- 
tained with Kex2p, where a mutation that deleted the cyto- 
plasmic domain and part of the membrane-spanning  domain 
resulted in a significant proportion of the Kex2p activity be- 
ing mislocalized to the cell surface (Fuller et al., 1989). The 
Kex2p activity study did not, however, address whether the 
truncated  protein produced was membrane  associated;  if 
not, then the resulting  soluble protein would be expected to 
be secreted to the cell surface.  In addition,  the strain  used 
for such Kex2p activity studies contained wild-type activity 
levels of  vacuolar hydrolases (PEP4;  Jones, 1984) and, there- 
fore,  any  Kex2p  potentially  mislocalized  to  the  vacuole 
might be degraded and hence go undetected. 
Mislocalization  of membrane proteins to the lysosome 
does not appear to occur in mammalian systems where muta- 
tions that interfere  with the localization  of ER, Golgi, and 
lysosomal integral  membrane proteins result in their deliv- 
ery to the plasma membrane (Paabo et al., 1987; Machamer 
and Rose, 1987; Peters et al.,  1990). One exception to this 
observation in mammalian  systems  is the coronavirus E1 
protein, a type HI membrane protein normally resident in the 
Golgi apparatus.  Mutations that affect the retention  of this 
protein resulted in delivery to the lysosome rather than to the 
cell surface (Armstrong  et al.,  1990). 
A number of models could explain the observation that the 
membrane-associated mutant forms of Kexlp are deh'vered 
to the vacuole while the soluble truncated forms of Kexl are 
exported to the cell surface (Fig. 9). (1) The first model sug- 
gests that membrane-associated truncated forms of  Kexlp are 
misfolded, and as such may be targeted,  via an unknown 
mechanism,  to  the  vacuole for degradation.  This  model 
seems unlikely as all of the truncated forms of Kexlp, both 
soluble and membrane associated, have similar total pro- 
tease activity to that of the wild-type protein, suggesting that 
at a minimum the catalytic domain of the mutants has folded 
to a conformation similar  to that of wild type. In addition, 
these forms of Kexlp all exit the ER and reach the Golgi ap- 
paratus where they are both glycosylated and process killer 
toxin.  The misfolding targeting  model would be unusual in 
that  it must explain  the mislocalization  of the membrane- 
associated mutant forms of Kexlp yet allow the soluble forms 
to be secreted. Also, such a garbage pathway for delivery of 
misfolded mutant forms of Kexlp cannot explain the vacuolar 
localization  of highly expressed but presumably correctly 
folded  Kexlp.  (2)  The  second  model  proposes  that  the 
membrane-spanning  domain of Kexlp contains a  latent  or 
cryptic targeting signal for the vacuole. Studies are currently 
under way to address this possibility. It should be noted that 
although Kexlp is homologous to the vacuolar protein CPY, 
the homology does not extend to include the vacuolar target- 
ing signal  found in proCPY.  (3) The third model involves 
Kexlp-Hpa (-Bcl, -Hinc) being secreted to the plasma mem- 
brane by default, where it is then endocytosed and delivered 
to the vacuole. Such a "transient  appearance"  of Kexlp-Hpa 
(-Bcl, -Hint) at the cell surface would not be detected by the 
activity assay used or by indirect immunofluorescence.  Solu- 
ble Kexlp-AS,  having  reached the cell surface,  would be 
released into the medium and, hence, would not be endocy- 
tosed to the vacuole.  (4) The final model proposes that the 
vacuole  is  the  direct  default  destination  for  membrane- 
associated proteins that  enter the secretory pathway, such 
that membrane proteins lacking positive targeting/retention 
signals would be delivered to the vacuole. 
Work with DPAP B, a type II vacuolar membrane protein 
homologous to DPAP A, has shown that no domain of the 
protein contains positive targeting information  for the vacu- 
ole (Roberts et al., 1992). The targeting  signal for a second 
vacuolar  membrane protein, alkaline  phosphatase, has not 
been identified although the lumenal domain is not required 
for the correct localization  of this  protein  (Klionsky  and 
Emr, 1990). The authors concluded that the vacuolar-sorting 
determinant  must therefore reside in the cytoplasmic and/or 
membrane-spanning  domain of alkaline phosphatase, but in 
light of the data presented here and elsewhere (Roberts et al., 
1992), these results could be reinterpreted  to suggest that the 
membrane association of alkaline phosphatase mediates its 
vacuolar delivery. 
Given the results presented here, we favor models 3 and 
4 which are variants of each other in that both result in the 
delivery of Kexlp to the vacuole by default (no positive tar- 
geting signal involved) but differ in the delivery route. Model 
4, involving a direct Golgi-to-vacuole route, may be the most 
likely as delivery of the vacuolar membrane protein DPAP 
B does not involve transport to the plasma membrane and 
subsequent endocytosis (Roberts et al.,  1992). In addition, 
Kexlp-Bcl contains no cytoplasmic tail to participate  in clas- 
sical endocytosis. 
An important implication  of such default delivery is that 
yeast integral  membrane proteins  destined for the plasma 
membrane must have positive targeting information to either 
remain at the plasma membrane (proposal 3), or to avoid be- 
ing diverted to the vacuole (proposal 4). It is pertinent that 
a  mutation  in  the u-factor  receptor  (Ste3p),  an  integral 
plasma membrane protein,  results in delivery of this protein 
to the vacuole,  independent  of the plasma membrane (Ho- 
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the possibility that a plasma membrane targeting signal has 
been destroyed. 
Further work is proceeding to determine if the delivery 
route of Kexlp to the vacuole is via the plasma membrane, 
and whether plasma membrane proteins have positive target- 
ing/retention  information. 
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